We are live on ! Find out more
SGI

Summit Global Investments Portfolio holdings

AUM $1.83B
1-Year Est. Return 22.56%
This Fund
S&P 500
This Quarter Est. Return
+9.39%
1 Year Est. Return
+22.56%
3 Year Est. Return
+60.44%
5 Year Est. Return
+82.72%
10 Year Est. Return
–
AUM
$1.56B
AUM Growth
+$224M
Cap. Flow
+$107M
Cap. Flow %
6.86%
Top 10 Hldgs %
23.64%
Holding
660
New
197
Increased
199
Reduced
106
Closed
124

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$18.5M
2
BMY icon
Bristol-Myers Squibb
BMY
+$17.9M
3
MTUM icon
iShares MSCI USA Momentum Factor ETF
MTUM
+$9.92M
4
HSY icon
Hershey
HSY
+$8.28M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$8.11M

Top Sells

Rank Stock Value
1
INTU icon
Intuit
INTU
+$11.9M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$11.4M
3
INCY icon
Incyte
INCY
+$9.85M
4
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$8.36M
5
BBY icon
Best Buy
BBY
+$8.26M

Sector Composition

Rank Sector Weight
1 Technology 18.73%
2 Healthcare 12.12%
3 Financials 9.32%
4 Consumer Staples 9.11%
5 Consumer Discretionary 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BPMC
101
DELISTED
Blueprint Medicines
BPMC
$3.03M 0.19%
28,294
+4,202
+17% +$440K
SLM icon
102
SLM Corp
SLM
$5.15B
$2.85M 0.18%
144,782
+5,032
+4% +$92.2K
DCT
103
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
$2.81M 0.18%
93,488
+64,788
+226% +$2.08M
CHTR icon
104
Charter Communications
CHTR
$18.2B
$2.81M 0.18%
4,303
-156
-3% -$106K
FCN icon
105
FTI Consulting
FCN
$4.18B
$2.8M 0.18%
18,230
-1,395
-7% -$203K
CLX icon
106
Clorox
CLX
$12.7B
$2.76M 0.18%
15,815
+9,307
+143% +$1.55M
PG icon
107
Procter & Gamble
PG
$339B
$2.7M 0.17%
16,500
+3,232
+24% +$480K
INVA icon
108
Innoviva
INVA
$1.48B
$2.69M 0.17%
156,200
+99,200
+174% +$1.69M
ADSK icon
109
Autodesk
ADSK
$52.6B
$2.64M 0.17%
+9,389
New +$2.74M
MDB icon
110
MongoDB
MDB
$32.1B
$2.63M 0.17%
4,965
– –
INCY icon
111
Incyte
INCY
$24.4B
$2.61M 0.17%
35,601
-146,119
-80% -$9.85M
CHT icon
112
Chunghwa Telecom
CHT
$33B
$2.59M 0.17%
61,454
+7,939
+15% +$321K
HRL icon
113
Hormel Foods
HRL
$13.8B
$2.59M 0.17%
53,032
+94
+0.2% +$4.12K
EHC icon
114
Encompass Health
EHC
$12.4B
$2.59M 0.17%
+49,812
New +$2.57M
MUSA icon
115
Murphy USA
MUSA
$9.61B
$2.58M 0.17%
12,976
+1,452
+13% +$260K
EVH icon
116
Evolent Health
EVH
$447M
$2.57M 0.17%
+93,000
New +$2.67M
USHY icon
117
iShares Broad USD High Yield Corporate Bond ETF
USHY
$28.7B
$2.56M 0.16%
62,131
+3,635
+6% +$149K
WTW icon
118
Willis Towers Watson
WTW
$32B
$2.56M 0.16%
10,761
+3,686
+52% +$872K
PXD
119
DELISTED
Pioneer Natural Resource Co.
PXD
$2.54M 0.16%
13,977
-32
-0.2% -$5.89K
UNP icon
120
Union Pacific
UNP
$174B
$2.48M 0.16%
9,827
+30
+0.3% +$7.11K
XLE icon
121
State Street Energy Select Sector SPDR ETF
XLE
$37.7B
$2.48M 0.16%
89,208
+49,122
+123% +$1.39M
ORCL icon
122
Oracle
ORCL
$423B
$2.42M 0.16%
27,775
+256
+0.9% +$24K
AES icon
123
AES
AES
$10.5B
$2.42M 0.16%
+99,443
New +$2.42M
CB icon
124
Chubb
CB
$135B
$2.41M 0.15%
12,477
+123
+1% +$23.1K
FLO icon
125
Flowers Foods
FLO
$1.57B
$2.39M 0.15%
87,166
-3,164
-4% -$81.8K
3 4
5
6 7

Similar funds

SI
Standard Investments New York $1.83B AUM 4.12% 1-Year Est. Return
KAM
Kensington Asset Management Austin, Texas $1.84B AUM 13.95% 1-Year Est. Return
OQS
Occudo Quantitative Strategies Fort Lauderdale, Florida $1.84B AUM 22.15% 1-Year Est. Return
RP
Regal Partners Sydney, NSW, Australia $1.84B AUM 54.78% 1-Year Est. Return
ABTD
Arvest Bank Trust Division Dewey, Oklahoma $1.84B AUM 20.84% 1-Year Est. Return
FCIM
Fairview Capital Investment Management Greenbrae, California $1.84B AUM 13.39% 1-Year Est. Return
CPSAC
Chas P. Smith & Associates (CPS) Lakeland, Florida $1.84B AUM 13.62% 1-Year Est. Return
DWT
Dorsey & Whitney Trust Sioux Falls, South Dakota $1.82B AUM 19.69% 1-Year Est. Return

Summit Global Investments's Q4 2021 Portfolio in Review

As of Q4 2021, Summit Global Investments held 660 positions worth $1.56B, up 17% from $1.33B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Summit Global Investments deployed $107M of net new capital in Q4 2021, opening 197 new positions and adding to 199 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 95,044 shares worth $20.9M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Intuit, an estimated $11.9M trimmed.

  • Summit Global Investments's largest Q4 2021 buy was Vertex Pharmaceuticals: 95,044 shares worth $20.9M.
  • Summit Global Investments added most to Bristol-Myers Squibb in Q4 2021, an estimated $17.9M increase.
  • Summit Global Investments's biggest Q4 2021 reduction was Intuit, cutting an estimated $11.9M.
  • Summit Global Investments fully exited Regeneron Pharmaceuticals in Q4 2021, selling an estimated $11.4M.
  • Summit Global Investments's ten largest holdings make up 24% of its $1.56B portfolio in Q4 2021.
  • Summit Global Investments opened 197 new positions and closed 124 in Q4 2021.
  • Summit Global Investments's portfolio value rose 17% quarter-over-quarter to $1.56B.

Based on Summit Global Investments's 13F filing for Q4 2021, filed 14 Feb 2022.